(redirected from Risperdal)
Also found in: Medical.


An oral antipsychotic drug, C28H27FN4O2, that is a dopamine and serotonin antagonist and is used to treat schizophrenia and bipolar disorder.

[Perhaps (fluo)r(obenz)is(oxazole), one of its constituents (fluoro- + benz- + is(o)- + ox- + azole) + (pi)perid(ine) + -one.]


n risperidona
References in periodicals archive ?
In the criminal complaint, the DOJ charged that J&J's subsidiary Janssen Pharmaceuticals marketed the atypical antipsychotic drug Risperdal to the elderly and children for off-label treatment that the U.
Johnson & Johnson agreed to resolve criminal and civil probes into the marketing of Risperdal, an antipsychotic drug, and other medicines by paying more than $2.
SeeNews) - Nov 6, 2013 - The US unit ofA Belgian Janssen Pharmaceutica will pay a USD-334-million (EUR 247m) fine to avoid prosecution for improper sales practicesA regarding antipsychoticA drug Risperdal.
Arkansas state judge Tim Fox has ordered Johnson & Johnson (J&J) to pay $181 million in fees to Houston-based Bailey Perrin Bailey for the work it did on a state Medicare fraud case involving the antipsychotic drug Risperdal.
1 billion after a jury found that the companies downplayed and hid risks associated with taking the antipsychotic drug Risperdal.
The Department of Justice has rejected a proposed $1 billion settlement from Johnson & Johnson on allegations of false advertising of the antipsychotic drug Risperdal and the schizophrenia treatment Invega.
Risperdal, a drug approved to treat psychotic behaviors, is sometimes prescribed for children with the behavioral issues.
M2 PHARMA-January 20, 2012-J&J agrees to pay USD158m to settle Risperdal case in Texas(C)2012 M2 COMMUNICATIONS
M2 EQUITYBITES-May 16, 2011-Mylan Inc announces generic Risperdal M-Tab for schizophrenia(C)2011 M2 COMMUNICATIONS http://www.
A district judge has ruled the Texas Attorney General's Office may continue its legal challenge against the drug company Janssen over its schizophrenia drug Risperdal.
Johnson & Johnson (New Brunswick NJ) lost a huge jury verdict in Louisiana for making misleading claims about the safety of the company's Risperdal antipsychotic drug.
NEW YORK: Johnson & Johnson paid leading US pharmacy group Omnicare to promote its antipsychotic drug Risperdal for elderly patients, the US government alleges in a lawsuit.